This article provides a list of autoimmune diseases . These conditions, where the body's immune system mistakenly attacks its own cells, affect a range of organs and systems within the body. Each disorder is listed with the primary organ or body part that it affects and the associated autoantibodies that are typically found in people diagnosed with the condition. Each disorder is also categorized by its acceptance as an autoimmune condition into four levels: confirmed, probable, possible, and uncertain. This classification is based on the current scientific consensus and reflects the level of evidence supporting the autoimmune nature of the disorder. Lastly, the prevalence rate, specifically in the United States, is included to give a sense of how common each disorder is within the population.
The integumentary system, composed of the skin, hair, nails, and associated glands, serves as a protective barrier between the body and the environment. It also plays a critical role in regulating body temperature and maintaining fluid balance.
Disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Alopecia areata | Hair follicles | None specific | Confirmed | 2.1% | [1] [2] |
Autoimmune angioedema | Skin | C1 inhibitor | Probable | Less than 5,000 | [3] |
Autoimmune progesterone dermatitis | Skin | Progesterone | Probable | Extremely rare | [4] |
Autoimmune urticaria | Skin | IgG against IgE or IgE receptor | Probable | Not well established | [5] [6] |
Bullous pemphigoid | Skin | Anti-BP180, Anti-BP230 | Confirmed | 6-30 per 100,000 (mostly older adults) | [7] |
Cicatricial pemphigoid | Mucous membranes, sometimes skin | Anti-BP180, Anti-BP230 | Confirmed | Rare | [8] |
Dermatitis herpetiformis | Skin | Anti-tissue transglutaminase | Confirmed | 10 per 100,000 | [9] |
Dermatomyositis | Skin and muscles | Anti-Jo1, Anti-Mi2, Anti-SRP, Anti-TIF1 | Confirmed | 9 in 1,000,000 | [10] |
Discoid lupus erythematosus | Skin | ANA, Anti-dsDNA, Anti-Sm | Confirmed | Part of SLE prevalence (20-150 per 100,000) | [11] |
Epidermolysis bullosa acquisita | Skin | Anti-type VII collagen | Confirmed | Extremely rare | [12] |
Erythema nodosum | Skin | None specific | Possible | Not well established | [13] |
Gestational pemphigoid | Skin | Anti-BP180, Anti-BP230 | Confirmed | Rare | [14] |
Hidradenitis suppurativa | Skin | None specific | Uncertain | 1-4% | [15] |
Lichen planus | Skin, mucous membranes | None specific | Probable | 1% | [16] |
Lichen sclerosus | Skin | None specific | Probable | Rare | [17] |
Linear IgA disease | Skin | Anti-epidermal basement membrane IgA | Confirmed | Extremely rare | [18] |
Morphea | Skin | None specific | Probable | Not well established | [19] |
Psoriasis | Skin | Various, not specific | Confirmed | 2-3% | [20] |
Pemphigus vulgaris | Skin and mucous membranes | Anti-desmoglein 3, Anti-desmoglein 1 | Confirmed | 1-5 per 100,000 | [21] |
Scleroderma (systemic sclerosis) | Skin, organs | ANA, anti-Scl-70, anti-centromere | Confirmed | 240 per 1,000,000 | [22] |
Vitiligo | Skin | Various, not specific | Confirmed | 1% | [23] |
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Autoimmune enteropathy | Small intestine | Anti-enterocyte antibodies | Probable | Rare | [24] |
Autoimmune hepatitis | Liver | ANA, ASMA, anti-LKM1 | Confirmed | 1 in 10,000 to 1 in 50,000 | [25] |
Celiac disease | Small intestine | Anti-tissue transglutaminase antibodies (tTG), Endomysial antibody (EMA), Deamidated gliadin peptide (DGP) | Confirmed | 1 in 100 | [26] |
Crohn's disease | Digestive tract | ASCA, Anti-OmpC, Anti-CBir1, ANCA | Probable | 201 per 100,000 adults | [27] |
Pernicious anemia | Stomach | Anti-IF, Anti-parietal cell | Confirmed | 0.1% | [28] |
Ulcerative colitis | Colon and rectum | pANCA, ASCA | Probable | 249 per 100,000 adults | [29] |
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Rheumatic heart disease | Heart valves | Anti-streptolysin O (ASO), anti-DNase B | Confirmed | Declining due to improved treatment of strep throat | [30] |
Kawasaki disease | Coronary arteries | Unknown | Probable | 20 per 100,000 children under age 5 | [31] |
Giant cell arteritis | Large and medium arteries, can affect coronary arteries | None specific | Confirmed | 200 per 100,000 (over age 50) | [32] [33] |
Takayasu's arteritis | Large arteries, including the aorta | None specific | Confirmed | Rare, more common in East Asia | [33] [34] |
Behçet's disease | Small to large vessels in mouth, genitals, eyes, skin | None specific | Probable | [35] | |
Eosinophilic granulomatosis with polyangiitis (EGPA) | Small to medium vessels in respiratory tract, skin, heart, kidneys, nerves | ANCA | Confirmed | [36] | |
Granulomatosis with polyangiitis (GPA) | Small to medium vessels in respiratory tract, kidneys | c-ANCA/PR3-ANCA | Confirmed | [36] | |
IgA vasculitis (IgAV) | Small vessels in skin, joints, kidneys, gastrointestinal tract | IgA immune complexes | Probable | [37] | |
Leukocytoclastic vasculitis | Small vessels in skin | Various immune complexes | Probable | [38] | |
Lupus vasculitis | Small to medium vessels in multiple organs | ANA, anti-dsDNA, anti-Smith, others | Confirmed | [39] | |
Rheumatoid vasculitis | Small to medium vessels in skin, nerves, eyes, heart | Rheumatoid factor, ACPA | Probable | [40] | |
Microscopic polyangiitis (MPA) | Small vessels in kidneys, lungs, nerves, skin | p-ANCA/MPO-ANCA | Confirmed | [41] | |
Polyarteritis nodosa (PAN) | Medium to small vessels in kidneys, skin, muscles, joints, nerves | None specific | Probable | [42] | |
Polymyalgia rheumatica | Large to medium vessels in shoulders, hips | None specific | Possible | [43] | |
Urticarial vasculitis | Small vessels in skin | C1q antibodies | Probable | [44] | |
Vasculitis | All vessel sizes in multiple organs | Depends on specific type | Uncertain | [45] |
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Goodpasture syndrome | Kidneys, lungs | Anti-GBM antibodies | Confirmed | 1 per million people | [46] |
IgA nephropathy | Kidneys | IgA autoantibodies | Confirmed | 3.5 per 100,000 | [47] |
Membranous nephropathy | Kidneys | Anti-PLA2R antibodies | Confirmed | 10 per 100,000 | [48] |
Lupus nephritis | Kidneys | Anti-dsDNA, Anti-Sm, Anti-nuclear antibodies | Confirmed | Up to 60% of those with Lupus | [49] |
Interstitial nephritis | Kidneys | Various autoantibodies | Probable | Varies widely, often drug-induced | [50] |
Interstitial cystitis | Bladder | Anti-urothelial and anti-nuclear antibodies | Probable | 100-450 per 100,000 women, less common in men | [51] |
Primary sclerosing cholangitis | Bile ducts, can affect gallbladder | P-ANCA, Anti Smooth Muscle Antibodies (ASMA) | Confirmed | 1 per 100,000 | [52] |
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Acute disseminated encephalomyelitis | Central nervous system | Unknown | Confirmed | 0.8 per 100,000 | [53] |
Acute motor axonal neuropathy | Peripheral nerves | Anti-GM1 | Confirmed | Part of Guillain-Barré syndrome prevalence | [54] |
Anti-NMDA receptor encephalitis | Brain | Anti-NMDA receptor | Confirmed | 1.5 per million | [55] |
Autoimmune encephalitis | Brain | Various, depending on subtype (e.g., NMDA receptor antibodies, LGI1 antibodies) | Confirmed | Rare | [56] |
Balo concentric sclerosis | Central nervous system | Unknown | Probable | Rare | [57] |
Bickerstaff's encephalitis | Brain | Anti-GQ1b | Confirmed | Rare | [58] |
Chronic inflammatory demyelinating polyneuropathy | Peripheral nerves | Various, including anti-MAG | Confirmed | 1-2 per 100,000 | [59] |
Guillain-Barré syndrome | Peripheral nerves | Various, including anti-GM1, anti-GD1a | Confirmed | 1-2 per 100,000 | [60] |
Hashimoto's encephalopathy | Brain | Anti-thyroid (TPO, Tg) | Probable | Rare | [61] |
Idiopathic inflammatory demyelinating diseases | Central nervous system | Varies | Probable | Varies by specific disease | [62] |
Lambert–Eaton myasthenic syndrome | Neuromuscular junction (affecting both CNS and PNS) | Anti-VGCC | Confirmed | 0.5-2 per million | [63] |
Multiple sclerosis | Central nervous system | Unknown, but Oligoclonal bands often present in CSF | Confirmed | 90 per 100,000 | [64] |
Myasthenia gravis | Neuromuscular junction (affecting both CNS and PNS) | Anti-AChR, anti-MuSK | Confirmed | 20 per 100,000 | [65] |
Neuromyelitis optica (Devic's disease)/NMOSD | Optic nerves and spinal cord | AQP4-IgG (NMO-IgG) | Confirmed | 0.5 - 4 per 100,000 | [66] |
Restless legs syndrome | Central nervous system (thought to involve dopaminergic pathways) | Unknown | Uncertain | 5-15% (more common in older adults) | [67] |
Stiff-person syndrome | Central nervous system | Anti-GAD, anti-amphiphysin | Confirmed | Rare | [68] |
Sydenham's chorea | Brain | Anti-basal ganglia | Confirmed | Rare (linked to Group A streptococcal infection) | [69] |
Transverse myelitis | Spinal cord | Various, including anti-AQP4 | Probable | 1-8 per million | [70] |
Undifferentiated connective tissue disease (UCTD) | Various | ANA (antinuclear autoantibody) (HEp-2 cells) | Confirmed | 2 per 100,000 | [71] |
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Addison's disease | Adrenal glands | 21-hydroxylase antibodies | Confirmed | 0.93-1.4 per 10,000 | [72] |
Autoimmune oophoritis | Ovaries | Anti-ovarian antibodies | Probable | Rare | [73] |
Autoimmune orchitis | Testes | Anti-sperm antibodies | Probable | Rare | [74] |
Autoimmune pancreatitis | Pancreas | IgG4, Anti-CA2 antibodies | Confirmed | 0.82-1.3 per 100,000 | [75] |
Autoimmune polyendocrine syndrome type 1 (APS1) | Multiple endocrine organs | Various autoantibodies depending on the organs affected | Confirmed | 1 in 100,000 to 200,000 | [76] |
Autoimmune polyendocrine syndrome type 2 (APS2) | Multiple endocrine organs | Various autoantibodies depending on the organs affected | Confirmed | 1 in 20,000 | [77] |
Autoimmune polyendocrine syndrome type 3 (APS3) | Multiple endocrine organs | Various autoantibodies depending on the organs affected | Confirmed | Rare | [77] |
Diabetes mellitus type 1 | Pancreas | Anti-insulin, anti-IA-2, anti-GAD, anti-ZnT8 antibodies | Confirmed | 1.6 per 1,000 | [78] |
Endometriosis | Endometrium | Anti-endometrial antibodies | Probable | 6-10% of women of reproductive age | [79] |
Graves' disease | Thyroid gland | TSI, TPO, TG antibodies | Confirmed | 1.2% of the population | [80] |
Hashimoto's thyroiditis | Thyroid gland | TPO, TG antibodies | Confirmed | 5% of the population | [81] |
Ord's thyroiditis | Thyroid gland | TPO, TG antibodies | Confirmed | Rare | [82] |
Sjögren syndrome | Exocrine glands (salivary and lacrimal glands) | Anti-SSA/Ro, Anti-SSB/La antibodies | Confirmed | 0.1-4% of the population | [83] |
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Goodpasture syndrome | See urinary system [a] | See urinary system | Confirmed | See urinary system | — |
Eosinophilic granulomatosis with polyangiitis (EGPA) | See vascular system [b] | See vascular system | Confirmed | See vascular system | — |
Granulomatosis with polyangiitis (GPA) | See vascular system [c] | See vascular system | Confirmed | See vascular system | — |
Idiopathic pulmonary fibrosis | Lungs | None specific | Possible | 20 per 100,000 (men), 13 per 100,000 (women) | [84] |
Interstitial lung disease | Lungs | Depends on the subtype (e.g. Anti-Jo1 in Anti-synthetase syndrome) | Probable | 31.5 per 100,000 (men), 26.1 per 100,000 (women) | [85] |
Pulmonary alveolar proteinosis | Lungs | Anti-GM-CSF antibodies | Confirmed | 6.2 per million | [86] |
Rheumatoid lung disease | Lungs | Rheumatoid factor, Anti-CCP antibodies | Confirmed | Part of RA prevalence (about 1%) | [87] |
Sarcoidosis | Lungs and other organs | None specific | Confirmed | 10 - 40 per 100,000 | [88] |
Autoimmune disease | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|
Autoimmune hemolytic anemia | Anti-red blood cell antibodies | Confirmed | 1-3 per 100,000 | [89] |
Immune thrombocytopenia | Anti-platelet antibodies | Confirmed | 3.3 per 100,000 (adults), 50 per 100,000 (children) | [90] |
Thrombotic thrombocytopenic purpura | ADAMTS13 autoantibodies | Confirmed | 1-2 per million | [91] |
Antiphospholipid syndrome | Antiphospholipid antibodies | Confirmed | 40-50 per 100,000 | [92] |
Paroxysmal nocturnal hemoglobinuria | None specific, mutation causes self-cells to become susceptible to attack | Possible | 1-2 per million | [93] |
The reproductive system is responsible for the production and regulation of sex hormones, the formation of germ cells, and the nurturing of fertilized eggs. In women, it includes structures such as ovaries, fallopian tubes, a uterus, and a vagina, while in men, it includes testes, vas deferens, seminal vesicles, prostate, and the penis. Autoimmune diseases of the reproductive system can affect both male and female fertility and reproductive health.
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Autoimmune orchitis | Testes | Anti-sperm antibodies | Probable | Not well established | [94] |
Autoimmune oophoritis | Ovaries | Anti-ovarian antibodies | Probable | Not well established | [94] |
Endometriosis | Uterus, ovaries, and pelvic tissue | Various, including anti-endometrial antibodies | Probable | Approx. 10% of women of reproductive age | [95] |
Premature ovarian failure | Ovaries | Anti-ovarian antibodies, Anti-adrenal antibodies | Confirmed | 1% of women under 40 years | [96] |
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Autoimmune retinopathy | Retina | Various | Confirmed | [97] | |
Autoimmune uveitis | Uvea | Various | Confirmed | [98] | |
Cogan syndrome | Inner ear and eye | None specific | Probable | [99] | |
Graves' ophthalmopathy | Eye muscles and connective tissue | TSH receptor antibodies | Confirmed | [100] | |
Intermediate uveitis | Uvea (pars plana) | Various | Probable | [101] | |
Ligneous conjunctivitis | Conjunctiva | Plasminogen deficiency | Possible | Rare | [102] |
Mooren's ulcer | Cornea | None specific | Probable | Rare | [103] |
Neuromyelitis optica | Optic nerve and spinal cord | Anti-AQP4 | Confirmed | [104] | |
Opsoclonus myoclonus syndrome | Central nervous system, eye movement control | Anti-neuronal antibodies | Possible | [105] | |
Optic neuritis | Optic nerve | Various | Confirmed | [106] | |
Scleritis | Sclera | Various | Possible | [107] | |
Susac's syndrome | Retina, cochlea, and brain | None specific | Probable | [108] | |
Sympathetic ophthalmia | Uveal tract | Various | Probable | Rare | [109] |
Tolosa–Hunt syndrome | Orbit | None specific | Uncertain | Rare | [110] |
These autoimmune diseases are primarily associated with the muscles, joints and neuromuscular function.
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disorder | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Dermatomyositis | See integumentary system [d] | See integumentary system | Confirmed | See integumentary system | — |
Fibromyalgia | Musculoskeletal system, pain perception | None specific | Possible | [111] | |
Inclusion body myositis | Proximal and distal muscles | None specific | Probable | [112] | |
Myositis | Skeletal muscles | Various, depends on subtype | Confirmed | [113] | |
Myasthenia gravis | Voluntary muscles, neuromuscular junctions | Anti-acetylcholine receptor, Anti-MuSK | Confirmed | [114] | |
Neuromyotonia | Peripheral nerves affecting muscle control | Anti-voltage-gated potassium channels | Probable | [115] | |
Paraneoplastic cerebellar degeneration | Central nervous system, cerebellum | Anti-Yo, Anti-Hu, Anti-Ri, others | Confirmed | [116] | |
Rheumatoid arthritis | Big and small joints of extremities, temporomandibular joints | Citrullinated proteins | Confirmed | 0.5 - 1% | |
Polymyositis | Proximal skeletal muscles | Anti-Jo-1, Anti-SRP, others | Confirmed | [117] |
This list includes conditions that are not diseases, but symptoms or syndromes common to autoimmune disease. [118]
At this time, there is not sufficient evidence to indicate that these diseases are caused by autoimmunity.
Disease | Reason not believed to be autoimmune | Cit. |
---|---|---|
Agammaglobulinemia | An immune system disorder but not an autoimmune disease. | |
Amyloidosis | No consistent evidence of association with autoimmunity. | |
Amyotrophic lateral sclerosis | No consistent evidence of association with autoimmunity. | |
Anti-tubular basement membrane nephritis | No consistent evidence of association with autoimmunity. | |
Atopic allergy | A hypersensitivity. | |
Atopic dermatitis | A hypersensitivity. | |
Autism | No consistent evidence of association with maternal autoimmunity. | |
Blau syndrome | Overlaps both sarcoidosis and granuloma annulare. No evidence of association with autoimmunity. | |
Cancer | No consistent evidence of association with autoimmunity. | |
Castleman's disease | An immune system disorder but not an autoimmune disease. | |
Chagas disease | No consistent evidence of association with autoimmunity. | [121] |
Chronic obstructive pulmonary disease | No consistent evidence of association with autoimmunity. | [122] [123] |
Chronic recurrent multifocal osteomyelitis | LPIN2, D18S60. Synonyms: Majeed syndrome. | |
Complement component 2 deficiency | Possibly symptomatic of autoimmune diseases, but not a disease. | |
Congenital heart block | May be related to autoimmune activity in the mother. | |
Contact dermatitis | A hypersensitivity. | |
Cushing's syndrome | No consistent evidence of association with autoimmunity. | |
Cutaneous leukocytoclastic angiitis | No consistent evidence of association with autoimmunity. | |
Dego's disease | No consistent evidence of association with autoimmunity. | |
Eosinophilic gastroenteritis | Possibly a hypersensitivity. | |
Eosinophilic pneumonia | A class of diseases, some of which may be autoimmune. | |
Erythroblastosis fetalis | Mother's immune system attacks fetus. An immune system disorder but not autoimmune. | |
Fibrodysplasia ossificans progressiva | Possibly an immune system disorder but not autoimmune. | |
Gastrointestinal pemphigoid | No consistent evidence of association with autoimmunity. | |
Hypogammaglobulinemia | An immune system disorder but not autoimmune. | |
Idiopathic giant-cell myocarditis | No consistent evidence of autoimmune cause though the disease has been found comorbid with other autoimmune diseases. | [124] |
Idiopathic pulmonary fibrosis | Autoantibodies: SFTPA1, SFTPA2, TERT, and TERC. | |
IgA nephropathy | An immune system disorder but not an autoimmune disease. | |
IPEX syndrome | A genetic mutation in FOXP3 that leads to autoimmune diseases, but not an autoimmune disorder itself. | |
Ligneous conjunctivitis | No consistent evidence of association with autoimmunity. | |
Majeed syndrome | No consistent evidence of association with autoimmunity. | |
Narcolepsy | No evidence of association with autoimmunity. Research not reproducible.[ needs update ] | [125] [126] [127] [128] |
Rasmussen's encephalitis | No consistent evidence of association with autoimmunity. | |
Schizophrenia | No consistent evidence of association with autoimmunity. | [129] [130] [131] |
Serum sickness | A hypersensitivity. | |
Spondyloarthropathy | No consistent evidence of association with autoimmunity. | |
Sweet's syndrome | No consistent evidence of association with autoimmunity. | |
Takayasu's arteritis | No consistent evidence of association with autoimmunity. | |
Undifferentiated spondyloarthropathy |
In immunology, autoimmunity is the system of immune responses of an organism against its own healthy cells, tissues and other normal body constituents. Any disease resulting from this type of immune response is termed an "autoimmune disease". Prominent examples include celiac disease, diabetes mellitus type 1, Henoch–Schönlein purpura, systemic lupus erythematosus, Sjögren syndrome, eosinophilic granulomatosis with polyangiitis, Hashimoto's thyroiditis, Graves' disease, idiopathic thrombocytopenic purpura, Addison's disease, rheumatoid arthritis, ankylosing spondylitis, polymyositis, dermatomyositis, and multiple sclerosis. Autoimmune diseases are very often treated with steroids.
Sex differences in medicine include sex-specific diseases or conditions which occur only in people of one sex due to underlying biological factors ; sex-related diseases, which are diseases that are more common to one sex ; and diseases which occur at similar rates in males and females but manifest differently according to sex.
Vasculitis is a group of disorders that destroy blood vessels by inflammation. Both arteries and veins are affected. Lymphangitis is sometimes considered a type of vasculitis. Vasculitis is primarily caused by leukocyte migration and resultant damage. Although both occur in vasculitis, inflammation of veins (phlebitis) or arteries (arteritis) on their own are separate entities.
Hypereosinophilic syndrome is a disease characterized by a persistently elevated eosinophil count in the blood for at least six months without any recognizable cause, with involvement of either the heart, nervous system, or bone marrow.
Connective tissue disease, also known as connective tissue disorder, or collagen vascular diseases, refers to any disorder that affects the connective tissue. The body's structures are held together by connective tissues, consisting of two distinct proteins: elastin and collagen. Tendons, ligaments, skin, cartilage, bone, and blood vessels are all made of collagen. Skin and ligaments contain elastin. The proteins and the body's surrounding tissues may suffer damage when these connective tissues become inflamed.
Selective immunoglobulin A (IgA) deficiency (SIgAD) is a kind of immunodeficiency, a type of hypogammaglobulinemia. People with this deficiency lack immunoglobulin A (IgA), a type of antibody that protects against infections of the mucous membranes lining the mouth, airways, and digestive tract. It is defined as an undetectable serum IgA level in the presence of normal serum levels of IgG and IgM, in persons older than 4 years. It is the most common of the primary antibody deficiencies. Most such persons remain healthy throughout their lives and are never diagnosed.
Pili torti is characterized by short and brittle hairs that appear flattened and twisted when viewed through a microscope.
An autoimmune disease is a condition that results from an anomalous response of the adaptive immune system, wherein it mistakenly targets and attacks healthy, functioning parts of the body as if they were foreign organisms. It is estimated that there are more than 80 recognized autoimmune diseases, with recent scientific evidence suggesting the existence of potentially more than 100 distinct conditions. Nearly any body part can be involved.
Autoimmune progesterone dermatitis(APD) occurs during the luteal phase of a woman's menstrual cycle and is an uncommon cyclic premenstrual reaction to progesterone. It can present itself in several ways, including eczema, erythema multiforme, urticaria, angioedema, and progesterone-induced anaphylaxis. The first case of autoimmune progesterone dermatitis was identified in 1964. Reproductive function may be impacted by APD.
Necrotizing vasculitis, also called systemic necrotizing vasculitis, is a general term for the inflammation of veins and arteries that develops into necrosis and narrows the vessels.
Linear IgA bullous dermatosis is a rare immune-mediated blistering skin disease frequently associated with medication exposure, especially vancomycin, with men and women being equally affected. It was first described by Tadeusz Chorzelski in 1979 and may be divided into two types:
Scleroderma is a group of autoimmune diseases that may result in changes to the skin, blood vessels, muscles, and internal organs. The disease can be either localized to the skin or involve other organs, as well. Symptoms may include areas of thickened skin, stiffness, feeling tired, and poor blood flow to the fingers or toes with cold exposure. One form of the condition, known as CREST syndrome, classically results in calcium deposits, Raynaud's syndrome, esophageal problems, thickening of the skin of the fingers and toes, and areas of small, dilated blood vessels.
Rheumatoid neutrophilic dermatitis, also known as rheumatoid neutrophilic dermatosis, is a cutaneous condition associated with rheumatoid arthritis.
Mouth and genital ulcers with inflamed cartilage syndrome or MAGIC syndrome is a condition in which an individual exhibits symptoms of both relapsing polychondritis (RP) and Behcet's disease (BD). Inflammatory ulcers in the mouth, genitalia, and skin are the hallmark of Behcet's disease (BD), a multisystem illness that is chronic and relapsing. Autoimmune recurrent chondritis of the larynx, tracheobronchial tree, nose, ears, and mouth is known as relapsing polychondritis (RP).
Antisynthetase syndrome (ASS) is a multisystematic autoimmune disease associated with inflammatory myositis, interstitial lung disease, and antibodies directed against various synthetases of aminoacyl-transfer RNA. Other common symptoms include mechanic's hands, Raynaud's phenomenon, arthritis, and fever.
Chronic spontaneous urticaria(CSU) also known as Chronic idiopathic urticaria(CIU) is defined by the presence of wheals, angioedema, or both for more than six weeks. The most common symptoms of chronic spontaneous urticaria are angioedema and hives that are accompanied by itchiness.
Autoimmune enteropathy is a rare autoimmune disorder characterized by weight loss from malabsorption, severe and protracted diarrhea, and autoimmune damage to the intestinal mucosa. Autoimmune enteropathy typically occurs in infants and younger children however, adult cases have been reported in literature. Autoimmune enteropathy was first described by Walker-Smith et al. in 1982.
Autoimmune polyendocrine syndrome, type 3 is a condition characterized by the coexistence of autoimmune thyroiditis and at least one other autoimmune disease. Based on other organ-specific autoimmune involvement, there are multiple subtypes that are classified: type 3a shows thyroid autoimmune disease in conjunction with type 1 diabetes, type 3b shows thyroid autoimmune disease in conjunction with pernicious anemia (PA), and type 3c shows thyroid autoimmune disease in conjunction with alopecia, vitiligo, or other organ-specific autoimmune disease.
Autoimmunity refers to a pathological immune response of the body's immune system against itself. Autoimmune disease is widely recognized to be significantly more common in women than in men, and often presents differently between the sexes. The reasons for these disparities are still under investigation, but may in part involve the presence of an additional X chromosome in women, as well as the higher presence of female sex hormones such as estrogen. The risk, incidence, and character of autoimmune disease in women may also be associated with female-specific physiological changes, such as hormonal shifts during menses, pregnancy, and menopause.
Autoimmune urticaria, also known as chronic autoimmune urticaria, is a type of chronic urticaria characterized by the presence of autoantibodies in the patient's immune system that target the body's own mast cells, leading to episodes of hives (urticaria). This immunologically distinct type of urticaria is considered autoimmune because the immune system, which normally protects the body from foreign organisms, mistakenly attacks the body's own cells, causing inflammation and other symptoms.